<DOC>
	<DOCNO>NCT01095952</DOCNO>
	<brief_summary>The aim multi-center research study evaluate performance ( primary purpose ) safety new algorithm aim control ventricular rate ( VR ) rapidly conduct atrial fibrillation ( AF ) deliver AV node stimulation ( AVNS ) atrial lead place septal position , design purpose reduce inappropriate shock . Additional purpose include assessment possible application AVNS aim allow prolonged control VR AF reduce AF symptom , evaluation implantation data selective placement atrial lead postero-septal right atrium . About 37 patient follow half year .</brief_summary>
	<brief_title>AV-node Stimulation Clinical Download Study Reduce Ventricular Rate During AF</brief_title>
	<detailed_description>The aim multi-center research study evaluate performance ( primary purpose ) safety new algorithm aim control VR rapidly conduct AF deliver AVNS atrial lead place septal position , design purpose reduce inappropriate shock . Additional purpose include assessment possible application AVNS aim allow prolonged control VR AF reduce AF symptom , evaluation implantation data selective placement atrial lead postero-septal right atrium . About 37 patient follow half year .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patients document history paroxysmal persistent AF eligible enrol study one follow criterion meet : Indication CRT implant accord current Guidelines ( Heart Failure , NYHA IIIIV class , symptomatic despite optimal stable medical therapy , leave ventricular ( LV ) ejection fraction ≤35 % QRS≥120ms ) ; OR Indication upgrading CRTD single chamber device ; OR Indication upgrading CRTD dual chamber device septal atrial lead dislodge atrial lead ; OR Indication device replacement surgical revision patient already implant CRTD device atrial lead septal position dislodge atrial lead ; OR Patients already implant ConsultaTM device atrial lead septal position , require electrical cardioversion . If follow criterion meet , patient enrol study : Permanent atrial fibrillation ; Patients anticoagulant therapy ; Advanced AV block ( IIIII degree AV block ) ; Patients previously submit valvular surgery ; Patients previously submit AV AF ablative procedure ; Age &lt; 18 year ; Patient dispose sign Informed Consent ; Participation study could potentially conflict study ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>inappropriate shock</keyword>
	<keyword>AV-node stimulation</keyword>
	<keyword>ventricular arrhythmia</keyword>
</DOC>